HOUSTON--(BUSINESS WIRE)--The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in children with recurrent high-grade glioma at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. There are no standard treatment recommendations for children with high-grade glioma after recurrence.
Help employers find you! Check out all the jobs and post your resume.
